Sources | Names Used |
---|---|
GDSC1000 | Elesclomol |
PharmacoGx | Elesclomol |
Database | Identifier |
---|---|
Smiles: | CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2 |
Inchikey: | BKJIXTWSNXCKJH-UHFFFAOYSA-N |
Pubchem: | 300471 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RGL3 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | HTATIP2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | POLR2L | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | PHF19 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | CELSR1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TNFAIP8 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | FBXO2 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | C18orf25 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | ISYNA1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | RPUSD2 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |